Safety outcomes in advanced non-small-cell lung cancer patients treated with first-line platinum-based regimens in the United States.

Conclusions: While EMR data have limitations, the real-world safety outcome with individual chemotherapy regimen could be considered for the better selection of platinum-based therapies in NSCLC. PMID: 31903235 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research